vs

Side-by-side financial comparison of Avery Dennison (AVY) and CME Group (CME). Click either name above to swap in a different company.

Avery Dennison is the larger business by last-quarter revenue ($2.3B vs $1.9B, roughly 1.2× CME Group). Avery Dennison runs the higher net margin — 7.3% vs 0.1%, a 7.3% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (14.5% vs 7.0%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs 1.4%).

Avery Dennison Corporation is an American multinational manufacturer and distributor of pressure-sensitive adhesive materials, apparel branding labels and tags, RFID inlays, and specialty medical products. The company is a member of the Fortune 500 and is headquartered in Mentor, Ohio.

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

AVY vs CME — Head-to-Head

Bigger by revenue
AVY
AVY
1.2× larger
AVY
$2.3B
$1.9B
CME
Growing faster (revenue YoY)
CME
CME
+7.5% gap
CME
14.5%
7.0%
AVY
Higher net margin
AVY
AVY
7.3% more per $
AVY
7.3%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
1.4%
AVY

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
AVY
AVY
CME
CME
Revenue
$2.3B
$1.9B
Net Profit
$168.1M
$1.2M
Gross Margin
28.9%
Operating Margin
10.7%
0.1%
Net Margin
7.3%
0.1%
Revenue YoY
7.0%
14.5%
Net Profit YoY
1.1%
20.7%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVY
AVY
CME
CME
Q1 26
$2.3B
$1.9B
Q4 25
$2.3B
$1.6B
Q3 25
$2.2B
$1.5B
Q2 25
$2.2B
$1.7B
Q1 25
$2.1B
$1.6B
Q4 24
$2.2B
$1.5B
Q3 24
$2.2B
$1.6B
Q2 24
$2.2B
$1.5B
Net Profit
AVY
AVY
CME
CME
Q1 26
$168.1M
$1.2M
Q4 25
$166.4M
$1.2B
Q3 25
$166.3M
$908.0M
Q2 25
$189.0M
$1.0B
Q1 25
$166.3M
$956.2M
Q4 24
$174.0M
$874.6M
Q3 24
$181.7M
$912.8M
Q2 24
$176.8M
$883.2M
Gross Margin
AVY
AVY
CME
CME
Q1 26
28.9%
Q4 25
28.7%
Q3 25
28.7%
Q2 25
28.8%
Q1 25
28.9%
Q4 24
27.9%
Q3 24
28.7%
Q2 24
29.6%
Operating Margin
AVY
AVY
CME
CME
Q1 26
10.7%
0.1%
Q4 25
9.1%
61.8%
Q3 25
10.6%
63.3%
Q2 25
11.5%
66.7%
Q1 25
10.6%
67.5%
Q4 24
11.0%
62.1%
Q3 24
11.0%
64.6%
Q2 24
10.7%
65.3%
Net Margin
AVY
AVY
CME
CME
Q1 26
7.3%
0.1%
Q4 25
7.3%
71.7%
Q3 25
7.5%
59.1%
Q2 25
8.5%
60.6%
Q1 25
7.7%
58.2%
Q4 24
8.0%
57.3%
Q3 24
8.3%
57.6%
Q2 24
7.9%
57.6%
EPS (diluted)
AVY
AVY
CME
CME
Q1 26
Q4 25
$2.16
$3.24
Q3 25
$2.13
$2.49
Q2 25
$2.41
$2.81
Q1 25
$2.09
$2.62
Q4 24
$2.17
$2.40
Q3 24
$2.25
$2.50
Q2 24
$2.18
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVY
AVY
CME
CME
Cash + ST InvestmentsLiquidity on hand
$255.1M
$2.4B
Total DebtLower is stronger
$3.2B
$3.4B
Stockholders' EquityBook value
$2.3B
Total Assets
$9.0B
$202.0B
Debt / EquityLower = less leverage
1.38×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVY
AVY
CME
CME
Q1 26
$255.1M
$2.4B
Q4 25
$202.8M
$4.5B
Q3 25
$536.3M
$2.6B
Q2 25
$215.9M
$2.1B
Q1 25
$195.9M
$1.5B
Q4 24
$329.1M
$3.0B
Q3 24
$212.7M
$2.4B
Q2 24
$208.8M
$1.9B
Total Debt
AVY
AVY
CME
CME
Q1 26
$3.2B
$3.4B
Q4 25
$3.2B
Q3 25
$3.2B
Q2 25
$2.6B
Q1 25
$2.6B
Q4 24
$2.6B
Q3 24
$2.0B
Q2 24
$2.0B
Stockholders' Equity
AVY
AVY
CME
CME
Q1 26
$2.3B
Q4 25
$2.2B
$28.7B
Q3 25
$2.2B
$28.2B
Q2 25
$2.2B
$27.7B
Q1 25
$2.2B
$27.0B
Q4 24
$2.3B
$26.5B
Q3 24
$2.4B
$28.2B
Q2 24
$2.3B
$27.6B
Total Assets
AVY
AVY
CME
CME
Q1 26
$9.0B
$202.0B
Q4 25
$8.8B
$198.4B
Q3 25
$8.9B
$187.1B
Q2 25
$8.6B
$179.9B
Q1 25
$8.4B
$157.8B
Q4 24
$8.4B
$137.4B
Q3 24
$8.5B
$137.8B
Q2 24
$8.3B
$123.4B
Debt / Equity
AVY
AVY
CME
CME
Q1 26
1.38×
Q4 25
1.43×
Q3 25
1.45×
Q2 25
1.19×
Q1 25
1.19×
Q4 24
1.11×
Q3 24
0.85×
Q2 24
0.89×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVY
AVY
CME
CME
Operating Cash FlowLast quarter
Free Cash FlowOCF − Capex
$104.4M
FCF MarginFCF / Revenue
4.5%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$869.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVY
AVY
CME
CME
Q1 26
Q4 25
$376.8M
$1.1B
Q3 25
$312.1M
$968.1M
Q2 25
$208.8M
$1.1B
Q1 25
$-16.3M
$1.1B
Q4 24
$351.2M
$1.0B
Q3 24
$270.1M
$1.0B
Q2 24
$197.7M
$776.9M
Free Cash Flow
AVY
AVY
CME
CME
Q1 26
$104.4M
Q4 25
$309.7M
$1.1B
Q3 25
$276.2M
$949.7M
Q2 25
$178.8M
$1.0B
Q1 25
$-52.3M
$1.1B
Q4 24
$281.7M
$991.7M
Q3 24
$227.1M
$973.2M
Q2 24
$150.2M
$758.7M
FCF Margin
AVY
AVY
CME
CME
Q1 26
4.5%
Q4 25
13.6%
66.8%
Q3 25
12.5%
61.8%
Q2 25
8.1%
61.5%
Q1 25
-2.4%
67.1%
Q4 24
12.9%
65.0%
Q3 24
10.4%
61.4%
Q2 24
6.7%
49.5%
Capex Intensity
AVY
AVY
CME
CME
Q1 26
Q4 25
3.0%
2.0%
Q3 25
1.6%
1.2%
Q2 25
1.4%
1.1%
Q1 25
1.7%
0.9%
Q4 24
3.2%
1.7%
Q3 24
2.0%
1.9%
Q2 24
2.1%
1.2%
Cash Conversion
AVY
AVY
CME
CME
Q1 26
Q4 25
2.26×
0.96×
Q3 25
1.88×
1.07×
Q2 25
1.10×
1.03×
Q1 25
-0.10×
1.17×
Q4 24
2.02×
1.16×
Q3 24
1.49×
1.10×
Q2 24
1.12×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AVY
AVY

Materials Group$1.6B72%
Solutions Group$649.2M28%

CME
CME

Segment breakdown not available.

Related Comparisons